Transcriptomic atlases now reveal that VSIG2 is not confined to the thymus but is highly enriched in gastric and colonic epithelia, renal tubules, and critically tumour-associated macrophages and B cells[7]. This evidence concerns the gene VSIG2 and neoplasm.